Culture

Academy scientists describe 213 species in 2020

image: Despite living just off the coast of bustling Sydney, Australia, this pipefish, Stigmatophora harastii, was only just discovered.

Image: 
Andrew Trevor-Jones © 2020

SAN FRANCISCO (December 9, 2020) -- This past year, researchers at the California Academy of Sciences added 213 plant and animal species to the tree of life, providing deeper insight into the rich biodiversity of our planet and helping to inform global conservation strategies. The new species include 101 ants, 22 crickets, 15 fishes, 11 geckos, 11 sea slugs, 11 flowering plants, eight beetles, eight fossil echinoderms, seven spiders, five snakes, two skinks, two aphids, two eels, one moss, one frog, one fossil amphibian, one seahorse, one fossil scallop, one sea biscuit, one fossil crinoid (or sea lily), and one coral. More than two dozen Academy scientists--along with many more collaborators throughout the world--described the new species.

While the coronavirus has presented unique challenges this year for Academy scientists--whose research typically involves expeditions or visits to scientific collections--it has also underscored the importance of their work. "Unfortunately, the pandemic is a symptom of our broken relationship with nature," says Academy virologist and Chief of Science Shannon Bennett, PhD. "These newly described species represent one aspect of a growing collective effort to mend that relationship. By improving our understanding of Earth's biodiversity and bringing us more in touch with the natural world, each new species serves as an important reminder--as does the pandemic--of our vital role in protecting our planet's ecosystems."

Below are thematic highlights from the 213 new species described by the Academy this past year. On January 7, 2021, there will be a virtual NightSchool event celebrating the new species, featuring several of the researchers who described them. For a full list of species and hi-res images, please contact press@calacademy.org.

Looking back moves science forward

For researchers interested in describing new species, there are few places more rich in taxonomic treasures than natural history collections like those found at the Academy. Colloquially known as a 'library of life,' the Academy's collections contain more than 46 million specimens representing many branches across the tree of life.

Since describing species takes time and expertise, a number of specimens in our collections represent species unknown to science. Indeed, that was the case for a number of this year's new species, including the striking bush pit viper, Atheris hetfieldi, which was described from a single Academy specimen collected in the early 1900s.

Importantly, the specimens found in natural history collections span both time and space, providing baseline data for the geographic distribution of species at various points in the past. For example, the collections used by Academy Curator of Botany Frank Almeda, PhD, and visiting researcher Ricardo Pacifico for this year's newly described flowering plants in the genus Microlicia provide researchers with potential locations in Brazil where they might find living specimens. Once found in the wild, the locations can be cross-referenced with information from the archived specimens to paint a picture of how the plant's range has changed over time--invaluable information when assessing the conservation status of the species.

To gain a deeper knowledge of these changes, however, requires specimens collected on geologic timescales--across millennia instead of centuries. Fortunately, fossils can provide these windows to the past.

"Fossils provide a unique opportunity to observe how past species, communities, and ecosystems have responded to environmental change," says Academy collections manager Christine Garcia, who described the fossil scallop Lyropecten terrysmithae, which lived in California around 11 million years ago. "Moreover, this evidence can offer insights into how modern species and ecosystems may respond to human-driven changes in the near future."

Amber fossils can be particularly insightful since they often preserve features that other fossils do not, such as muscle tissue or plant matter. Using this additional information, Academy Research Associate Aaron Bauer, PhD, and his colleagues determined that the amber-trapped amphibian Yaksha peretti likely used its tongue as a slingshot to catch prey, similar to modern-day chameleons, extending the evolutionary origins of this adaptation to 100 million years ago.

Technologies driving discoveries

After running a genetic analysis on an unknown species of sea slug, Lynn Bonomo, an early-career researcher working with Academy Curator of Invertebrate Zoology Terry Gosliner, PhD, was skeptical of her results. "I thought I had messed up," she recalls. According to her analysis, the new nudibranch was a member of Chromodoris, a colorful genus of sea slugs that typically sport prominent black stripes along the length of their bodies. But Bonomo's species, which she aptly named Chromodoris kalawakan ('kalawakan' means 'galaxy' in Filipino), is cloudy gray with pinpricks of white.

After double-checking the analysis and studying the internal morphology of the specimen, however, Gosliner confirmed the finding: C. kalawakan was in an entirely different genus than expected and Bonomo had the basis for describing her first species.

While it is exciting for a new species to bounce between genera, it is not uncommon. Even experts can misidentify unfamiliar species if the organisms lack the typical morphology of one genus or present those of another. To untangle these twisted branches on the tree of life, researchers turn to gene sequencing technologies, like those used by Bonomo, which determine the relationships between species through mathematical analyses.

In addition to morphology and genetics, researchers also use behavior to distinguish species. For example, when describing this year's new species of crickets, Academy Research Assistant David Weissman, PhD, partially relied on analyses of the insects' chirps. Using recording equipment and audio software, entomologists like Weissman capture the sound waves of cricket calls to compare with those of known species.

For some species, technology not only plays a significant role in how they are described but also how they are discovered. At up to 500 feet (approximately 150 meters) below the ocean's surface, mesophotic coral reefs pose challenges for conducting scientific research. Using traditional scuba gear to study these reefs would be impossible due to the intense pressure at such depths and the long duration necessary to reach them.

To overcome these oceanic obstacles, scientists at the Academy use revolutionary diving technologies. Closed-circuit rebreathers scrub the carbon dioxide from exhaled breaths, then return oxygenated air mixed with helium to the diver so they can observe beautiful new species, such as this year's Cirrhilabrus briangreenei, for longer at mesophotic depths.

Together these innovative technologies--gene sequencing, sound analysis, deep-sea diving equipment, and more--allow researchers to explore the biodiversity of our world like never before, adding both species and clarity to the tree of life.

Finding unfamiliar species in familiar places

Despite decades of scouring the Earth, it is estimated that more than 90% of species remain unknown to science. More humbling still, a number of the newly described species each year--including an inconspicuous pipefish--are found hidden in plain sight.

Off the coast of Botany Bay, Australia, a popular scuba diving site near Sydney, pipefish have long been known to exist in the shallows among seagrass or brown algae, hiding from would-be predators. Until Research Associate Graham Short, PhD, discovered Stigmatopora harastii, however, none had been documented in red algae before--brown algae's deepwater relative that's lower in abundance. By subverting researchers' expectations of the genus, this unique evolutionary advantage allowed S. harastii to not only avoid competition with shallow-dwelling pipefish that prefer brown algae, but evade scientific scrutiny as well.

In addition to cryptic behavior driven by evolution, another explanation for finding undescribed species in familiar places is human encroachment on nature. As major cities like Guwahati, India--home to the newly described gecko Crytodactylus urbanus--expand, surrounding ecosystems shrink. As a result, some species lose their preferred habitat and are forced out, while others well-suited to urban landscapes thrive, including some that are new to science.

Though urban expansion can be ecologically disruptive, community outreach can inspire appreciation for the species that still call concrete jungles home. Indeed, part of Research Associate Aaron Bauer's motivation for naming the gecko C. urbanus was to raise awareness about the value of urban species. "Since this diversity occurs where people live, it provides an opportunity for them to connect with nature in their own backyard," Bauer says. Importantly, this increased appreciation of local biodiversity can drive conservation efforts to protect these fragile environments.

From urban spaces to unexpected places, understanding biodiversity--particularly where humans and nature coexist and therefore where nature is most vulnerable--is crucial for effectively stewarding the planet. By continuing to scour the known for the unknown, researchers can deepen that understanding and further foster an appreciation for the natural world.

Credit: 
California Academy of Sciences

Big data offers promise of better groundwater management in California

To ensure that California's groundwater is sustainably managed in the future and over the long-term, current state definitions of what constitutes groundwater may need to be revised, according to research published this week in PNAS. A McGill University-led research team has analyzed big data of more than 200,000 groundwater samples taken from across the state and found that there are problems with the guidelines used for groundwater management. Known as the 'Base of Fresh Water', the guidelines are close to fifty years old and don't reflect current uses, knowledge, concerns or technologies related to managing groundwater in this coastal state with a multi-billion-dollar agricultural industry.

The research shows that existing groundwater wells already penetrate and encroach upon the bases of fresh water that are used to define basin bottoms. In addition, brackish waters exist within current groundwater basins, and fresh water exists outside delineated groundwater basins. Brackish water, which was once deemed unusable, can now be used, thanks to technological advances. Finally, there are concerns about regulating groundwater on the basis of its quality rather than its usage, as is currently the case, since this provides a loophole for potential groundwater users who could drill deeper and skirt existing restrictions on freshwater pumping.

Together, these findings suggest that groundwater may already be poorly safeguarded in some places and that the 'Base of Fresh Water' concept may need to be reconsidered as a means to define and sustainably manage groundwater in future.

Need for up-to-date information to manage a critical resource

"It is challenging for groundwater sustainability agencies to manage groundwater because this critical resource is not being sufficiently monitored," says Mary Kang, an Assistant Professor in McGill University's Department of Civil Engineering and the lead author on the study. An expert on groundwater issues, she has studied the topic in California since 2014. "The base of fresh water was historically set to protect high quality groundwater from oil and gas development. And we find that there is a mismatch between this base of fresh water and what the water quality data shows."

"One component to managing groundwater sustainably is evaluating the physical resource within the context of its users", says Debra Perrone co-author of the study and Assistant Professor in UC Santa Barbara's Environmental Studies Program. "We evaluate the link between groundwater quality, particularly salinity, and groundwater users. We show that the current approach used to manage deep groundwater in some places may risk overlooking the complex realities pertaining to both groundwater salinity and groundwater users. For example, the data suggest that people are constructing groundwater wells deeper than the base of fresh water in some areas."

In 2014, in response to repeated droughts, the state passed the Sustainable Groundwater Management Act (SGMA) to regulate groundwater for the first time in California's history. However, the effectiveness of this legislation is yet to be determined, as it relies upon administrative definitions of groundwater that are based on the extent of fresh water to define a vertical or three-dimensional groundwater basin for managing water.

"The Sustainable Groundwater Management Act currently only applies to fresh groundwater basins since administrative definitions of groundwater originated decades ago when it was economically infeasible to treat and distribute 'unusable' brackish or saline groundwater," says co-author Melissa Rohde, a scientist with The Nature Conservancy of California. Rohde is currently providing scientific support to advance the successful implementation of SGMA. "With technological advances, brackish water is now usable and increasingly desirable with declining access to fresh water. By excluding brackish groundwater from sustainable groundwater management, we run the risk of undermining SGMA and overexploiting this important public resource."

Credit: 
McGill University

Brains work harder while processing descriptions of motion in other languages

ATLANTA--We all run from a burning building the same way--fast!--but how we describe it depends on the language we speak. In some languages, we might flee, race, or bolt, while in others we might just exit or leave the building quickly..

Different languages describe motion differently, according to distinct lexical rules. And though we may not consciously notice those rules, we follow them--and Georgia State researchers have found they affect how our brains perceive and process descriptions of physical movement.

Our brain has to work a little harder when we're reading about physical movement in a way that is not typical in our native language, according to a new study by ?eyda Özçal??kan, an associate professor in the Department of Psychology at Georgia State University, former faculty member Christopher M. Conway, and Samantha Emerson, a former Georgia State University graduate student. Their study, "Semantic P600--but not N400--effects index crosslinguistic variability in speakers' expectancies for expression of motion" was published recently in the journal Neuropsychologia.

"Physical movement always has the same key components, no matter where you live in the world, no matter what language you speak," explains Özçal??kan. "But languages talk about it differently."

Languages such as English, Polish, German and Dutch include the manner in which we move in the actual verb (we bolt, race, dawdle, sashay). But other languages, such as Spanish, Turkish, Japanese or Korean, add the manner at the end as a modifier (we enter rapidly, we ascend slowly).

Languages also differ in the way they describe the path of physical movement. Spanish includes path in the verb: we descend the mountain, or more dramatically, we descend the mountain arduously. But other languages, such as English and German, add the path after the motion: we crawl down the mountain.

The way we habitually express motion becomes internalized, says Özçal??kan, and likely affects how we perceive our world, particularly when speaking. And when we're faced with another language's unfamiliar description, our brain has to work harder momentarily. This can actually be measured with an electroencephalogram (EEG), a test used to evaluate the electrical activity in the brain. In their new study, the researchers tested motion descriptions in English and Spanish and found a surprising pattern.

"We found a very interesting pattern which in scientific language is called the P600 effect," said Emerson, who now works at the Center for Childhood Deafness, Language, & Learning at Boys Town National Research Hospital in Omaha. "It is usually found in response to grammatical errors. We think that when you read a sentence structured in a way that is unfamiliar, you have to stop and go back and analyze it just as you would with a grammatical error."

Then your brain has to "repair" those violations to your expectations, Emerson said. That means your brain has to exert a stronger electrical signal.

This is the first study that has examined actual neural activity in the brain in response to cross-linguistic differences related to motion. "And this study follows a long line of research on motion events at our lab at Georgia State University," said Özçal??kan.

Previous studies in Özçal??kan's laboratory have looked at how individuals use their hands when speaking, which also differs strongly across languages. In future studies, the researchers want to test a variety of the world's languages, to see if the P600 pattern remains when describing physical movement. They also want to test Spanish and English bilingual speakers to see if there is still a P600 effect when one is fluent in both languages.

In the end, this kind of research can give us insights into how our brains interpret the world around us, influenced by language in ways we never would have expected or perhaps even noticed.

Credit: 
Georgia State University

Dogs may never learn that every sound of a word matters

image: Despite their excellent auditory capacities, dogs do not attend to differences between words which differ only in one speech sound (e.g. dog vs dig), according to a new study by Hungarian researchers of the MTA-ELTE 'Lendület' Neuroethology of Communication Research Group at the Eötvös Loránd University, Budapest (ELTE) measuring brain activity with non-invasive electroencephalography (EEG) on awake dogs. This might be a reason why the number of words dogs learn to recognize typically remains very low throughout their life. The study is published in Royal Society Open Science.

Image: 
Photo: Vivien Reicher

Despite their excellent auditory capacities, dogs do not attend to differences between words which differ only in one speech sound (e.g. dog vs dig), according to a new study by Hungarian researchers of the MTA-ELTE 'Lendület' Neuroethology of Communication Research Group at the Eötvös Loránd University, Budapest (ELTE) measuring brain activity with non-invasive electroencephalography (EEG) on awake dogs. This might be a reason why the number of words dogs learn to recognize typically remains very low throughout their life. The study is published in Royal Society Open Science.

Dogs can distinguish human speech sounds (e.g. "d", "o" and "g") and there are similarities in the neuronal processing of words between dogs and humans. However, most of the dogs can learn a few words only throughout their lives even if they live in a human family and are surrounded by human speech. Magyari and her colleagues hypothesized that despite dog's human-like auditory capacities for analyzing speech sounds, dogs might be less ready to attend to all differences between speech sounds when they listen to words.

To test this idea, the researchers developed a procedure for measuring electrical activity in the brain non-invasively on awake, untrained, family dogs. Electroencephalography (EEG) is an often used technique in human clinical and research studies and it has been also successfully applied on tranquilized, sleeping or awake but trained dogs. However, in this study, the researchers measured EEG on awake dogs without any specific training.

Researchers invited dogs and their owners to the lab. After the dog got familiar with the room and the experimenters, the experimenters asked the owner to sit down on a mattress together with her dog as it would be a relaxation time for them. Then, the experimenters put electrodes on the dog's head and fixed it with a tape. With the electrodes on, dogs listened to tape-recorded instruction words they knew (e.g. "sit"), to similar but nonsense words (e.g. "sut"), and to very different nonsense words (e.g. "bep").

Video abstract about the research: https://youtu.be/dNQTPmg1KWc

"The electroencephalography is a sensitive method not only to brain activity but also to muscle-movements. Therefore, we had to make sure that dogs tense their muscles as little as possible during measurement. We also wanted to include any type of family dogs in our study not only specially trained animals. Therefore, we decided that instead of training our dog-participants, we will ask them just to relax. Of course, some of the dogs who came to the experiment could not settle down and did not let us do the measurement. But the dropout rate from the study was similar to the dropout rate in EEG studies with human infants. It was also an exciting process for us to learn how we can create a relaxing and safe atmosphere in the lab for both the dogs and their owners." -says lead author Lilla Magyari, postdoctoral researcher at Department of Ethology, Eötvös Loránd University, Hungary.

The analysis of the recorded electric brain activity showed that dog brains clearly and quickly discriminated the known words from the very different nonsense words starting from 200 ms after the beginning of the words. This effect is in line with similar studies on humans which show that the human brain responds differently to meaningful and nonsense words already within a few hundred milliseconds. But the dogs' brains made no difference between known words and those nonsense words that differed in a single speech sound only. This pattern is more similar to the results of experiments with human infants who are around 14-months. Infants become efficient in processing phonetic details of words, which is an important prerequisite for developing a large vocabulary, between 14 and 20 months. But younger infants do not process phonetic details of words in certain experimental and word learning situations despite the fact that infants are able to differentiate speech sounds perceptually within weeks after birth.

"Similarly to the case of human infants, we speculate that the similarity of dogs' brain activity for instruction words they know and for similar nonsense words reflects not perceptual constraints but attentional and processing biases. Dogs might not attend to all details of speech sound when they listen to words. Further research could reveal whether this could be a reason that incapacitates dogs from acquiring a sizable vocabulary."- concludes Attila Andics, principal investigator of the MTA-ELTE 'Lendület' Neuroethology of Communication Research Group.

Credit: 
Eötvös Loránd University

Healthcare workers 7 times as likely to have severe COVID-19 as other workers

Healthcare workers are 7 times as likely to have severe COVID-19 infection as those with other types of 'non-essential' jobs, finds research focusing on the first UK-wide lockdown and published online in the journal Occupational & Environmental Medicine.

And those with jobs in the social care and transport sectors are twice as likely to do so, emphasising the need to ensure that essential (key) workers are adequately protected against the infection, say the researchers.

Few studies have looked at the differences in the risk of developing severe COVID-19 infection between different groups of workers. While it's known that those working in healthcare roles are at heightened risk, it's not clear what the risks might be for those working in other sectors.

The researchers therefore compared the risk of developing severe COVID-19 infection in essential and non-essential workers, drawing on linked data from the UK Biobank study (2006-10), COVID-19 test results from Public Health England, and recorded deaths for the period 16 March to 26 July 2020.

The UK Biobank is a long term study tracking the factors potentially influencing the development of disease in around half a million middle and older age adults.

Severe infection was defined as a positive test result for SARS-CoV-2, the virus responsible for COVID-19, while in hospital, or death attributable to the virus.

The study included 120,075 employees aged 49-64. Of these, 35,127 (29%) were classified as essential workers: healthcare (9%); social care and education (11%); 'other' to include police and those working in transport and food preparation (9%)

Those of Black and Asian ethnicities comprised nearly 3% each of the total. They were more likely to be essential workers, as were women.

In all, 271 employees had severe COVID-19 infection. Healthcare professionals, defined as doctors and pharmacists; medical support staff; health associate professionals, defined as nurses and paramedics; and social care and transport workers had higher rates of severe COVID-19 than non-essential workers.

Compared with non-essential workers, those working in healthcare roles were more than 7 times as likely to have severe infection.

And those working in social care and in education were 84% as likely to do so; while 'other' essential workers had a 60% higher risk of developing severe COVID-19.

When the researchers refined the employment categories further, it emerged that medical support staff were nearly 9 times as likely to develop severe disease; those in social care almost 2.5 times as likely to do so; while transport workers were twice as likely to do so.

And when the researchers looked at the impact of ethnicity, they found that the risks of severe infection for Black and Asian non-essential workers were similar to those for white essential workers, suggesting that ethnicity is a key factor.

Non-essential workers of Black and Asian backgrounds were also more than 3 times as likely to develop severe COVID-19 infection as white non-essential workers, while Black and Asian essential workers were more than 8 times as likely to do so.

With the exception of transport workers, for whom heightened risk of severe COVID-19 infection was linked to socioeconomic status, the findings held true even after accounting for potentially influential risk factors, including lifestyle, co-existing health problems, and work patterns.

This is an observational study, and therefore can't establish cause. And the authors acknowledge that their initial background data were collected more than a decade ago, so they were unable to account for any changes in health, lifestyle, income and employment status. The UK Biobank is also not representative of the broader population.

Nor were the researchers able to take account of the changes in risk over time, such as the availability of personal protective equipment (PPE). Nevertheless, the findings echo those of other studies, they point out.

And they conclude: "Our findings reinforce the need for adequate health and safety arrangements and provision of PPE for essential workers, especially in the health and social care sectors. The health and wellbeing of essential workers is critical to limiting the spread and managing the burden of global pandemics."

Credit: 
BMJ Group

Steep rise in depressive symptoms among 7-12 year olds during UK-wide lockdown

The prevalence of depressive symptoms rose substantially among young children during the UK-wide lockdown in response to the first wave of the coronavirus pandemic, finds research focusing on one region of England and published online in Archives of Disease in Childhood.

The effect size was medium to large, indicate the findings, which have implications for future partial or complete school closures, suggest the researchers.

Social distancing and school closures during the lengthy lockdown across the UK earlier this year are thought to have badly affected children's mental health.

But there has been little hard evidence to substantiate this, largely because it is hard to find good baseline data, for the same children, collected before the first lockdown on March 23.

The researchers were able to get round this by drawing on data on children living in the East of England who were part of the Resilience in Education and Development (RED) study.

During lockdown,168 of their parents--equivalent to 29% of the overall sample--completed online validated mental health assessments to rate their children's emotional wellbeing, anxiety and depression.

These ratings were then compared with baseline data collected around 18 months earlier, which included a mixture of parent-, teacher-, and child-rated mental health measures.

Compared with the initial baseline assessment, there were no significant changes in levels of anxiety or emotional wellbeing during lockdown.

But a significant increase of 0.74 in depressive symptoms was observed, the effect size of which was medium to large. Put simply, this means that, on average, there was around a 70% chance that depressive symptoms worsened during lockdown in any child.

These findings held true even after accounting for potentially influential factors, including age, gender, and socioeconomic status, although larger numbers of children are needed to confirm this, say the researchers.

To find out whether changes during lockdown might have been driven by specific items within the depression scale, the researchers looked at changes in responses to each individual question in the mental health scales.

This revealed significant increases for 4 out of 5 of the depression questions during lockdown in respect of lethargy, struggling to enjoy activities, and feelings of sadness or emptiness.

This is an observational study; the numbers are relatively small; and from one area of England only, so may not be more widely applicable, caution the researchers.

But they point out: "The backdrop is that children's mental health appears to be worsening across successive cohorts, and even before lockdown, the resources for Child and Adolescent Mental Health Services were stretched thin.

"The current findings suggest that lockdown measures will likely exacerbate this, specifically with an increase in childhood depression symptoms, something previously relatively uncommon in children of this age."

They add: "Our findings emphasise the need to incorporate the potential impact of lockdown on child mental health in planning the ongoing response to the global pandemic and the recovery from it."

Dr Karen Street is a paediatric consultant and mental health lead at the Royal College of Paediatrics and Child Health (RCPCH), which co-owns the journal with BMJ.

She commented: "This study reports what many paediatricians have observed--while children rarely become ill with COVID-19, they have been significantly affected by the measures taken to reduce transmission of the virus.

She added: "The RCPCH welcomes the government's ongoing commitment to keep schools open. It would also be good to see extra-curricular activities and opportunities for children and young people return as soon as possible.

"While we hope that for many children a return to normality will see a 'rebound' in their emotional wellbeing, we also know that the socioeconomic impact of lockdown for many families will be ongoing for many years, and that this will have secondary negative effects on the mental health of children.

"Persisting mental health problems in childhood and adolescence are associated with poor outcomes for educational attainment, employment, and long term physical and mental health so it is vital there is sufficient investment in health, education and the voluntary sector to support children's mental health as we recover from the pandemic."

Credit: 
BMJ Group

Long-term study of gene therapy technique in monkeys finds no adverse health effects

A decade after the birth of the first primates born with the aid of a gene therapy technique designed to prevent inherited mitochondrial disease, a careful study of the monkeys and their offspring reveals no adverse health effects.

Led by scientists at Oregon Health & Science University, the study published Dec. 8 in the journal Human Reproduction.

The new study generally bolsters the scientific basis for mitochondrial replacement therapy in human clinical trials, with an important caveat: Researchers found varying levels of carryover maternal mitochondrial DNA that had preferentially replicated and accumulated within some internal organs, although not enough to cause health effects.

"Our data show that MRT is compatible with normal development, fertility and aging in nonhuman primates without any detected adverse effects," the authors write. "However, carry-over maternal or paternal mtDNA contributions increased substantially in selected internal tissues/organs of some MRT animals, implying the possibility of mtDNA mutation recurrence."

Shoukhrat Mitalipov, Ph.D., director of the OHSU Center for Embryonic Cell and Gene Therapy, led the work.

Researchers say that the initial five rhesus macaque monkeys - born in 2009 - all developed normally to adulthood, and they observed normal healthy development in their offspring as well.

"It's reassuring that the monkeys appear to be healthy and fertile through generations," said co-author Paula Amato, M.D., professor of obstetrics and gynecology in the OHSU School of Medicine. "It adds to a growing body of evidence that would support moving forward with clinical trials to prevent the transmission of mitochondrial disease."

That won't happen in the United States, at least for the time being.

Through a budgetary rider, Congress has blocked the Food and Drug Administration from providing oversight for such clinical trials in the U.S. Even though the technique was developed at OHSU as a way to break the cycle of disease passed from mother to baby through mutations in mitochondrial DNA, it is only available overseas through clinical trials currently underway in the United Kingdom and Greece.

Mitochondria control respiration and energy production within every cell of the body, so mutations in mtDNA can cause a range of potentially fatal disorders affecting organs with high-energy demands such as the heart, muscle and brain. Mitalipov's mitochondrial replacement technique mitigates this problem by replacing disease-causing mitochondrial mutations in a mother's egg with donor mitochondria.

In 2009, researchers successfully demonstrated the technique with the birth of rhesus macaques at OHSU's Oregon National Primate Research Center.

The new study provides insight about their health over the long term and across generations.

"The question was always there about the long-term safety of this technique," Mitalipov said. "We wanted to find out whether this procedure will somehow show negative effects later in life. We saw no adverse health effects across two generations."

The study also provided important insight about the amount of maternal mtDNA detected within organs. This issue starts with a residual amount of maternal mtDNA that's carried over with the mother's nucleus to a donor egg stripped of its nucleus. This could be a big problem in cases where the technique is intended to prevent the transmission of disease-causing mtDNA from mother to child.

That's because as cells divide, this small remnant can preferentially replicate as the embryo develops - raising the potential for ultimately causing the very disease the therapy was designed to prevent.

Researchers found less than 3% maternal mtDNA in blood, urine and skin cells samples.

However, they also examined internal tissues and organs, after death, and found that initially negligible levels of maternal mtDNA had increased substantially, up to 16.6% in the small intestine. Researchers say this falls well below the level that would be considered disease-causing - and below the level that would be transmitted by a mother through ordinary reproduction.

"For most mutations, you'd need to have 60% mutant mtDNA to cause a disease," Mitalipov said.

It is also irrelevant in cases where the technique is used to treat infertility as opposed to preventing the transmission of known genetic mitochondrial disease.

The study made one other curious finding. Although mitochondrial DNA is normally passed from mother to child, the new study found that up to 33% of the mtDNA in selected tissues in two macaques had been contributed by the paternal line. This is unusual although not unprecedented, and Mitalipov said he is interested in learning more about why the minute level of mtDNA in sperm cells replicated exponentially as the cells divided and the embryos grew.

"Once you turn on this engine, it's like a power plant," Mitalipov said.

Credit: 
Oregon Health & Science University

Deep Longevity publishes an epigenetic aging clock of unprecedented accuracy

image: Aging is accompanied by specific patterns of epigenetic marks that attach to DNA and can be studied to understand subcellular aging mechanisms

Image: 
Fedor Galkin

8 December 2020 -- Deep Longevity, a Hong-Kong based longevity startup, has published their research on the epigenetics of aging in the Aging and Disease journal.

The article about DeepMAge describes a novel aging clock that was trained to predict human age on more than 6'000 DNA methylation profiles [1]. By analyzing the methylation patterns it can estimate human age within a 3-year error margin, which is more accurate than any other human aging clock [2].

Aging clocks boom started in 2013 when the first DNA methylation aging clocks by Horvath and Hannum were published [3, 4]. They have proven to be an indispensable tool in aging research, letting scientists understand its mechanisms and develop longevity interventions. Unlike its predecessors, DeepMAge is a neural network that may prove to be more efficient in some other ways apart from prediction accuracy. In the original paper, DeepMAge deems people with certain conditions to be older, which may be useful for the development of early diagnostics tools. For example, women with ovarian cancer are on average predicted 1.7 years older than healthy women of the same chronological age, and likewise, multiple sclerosis patients are predicted 2.1 years older. Similar results have been obtained for several other conditions: irritable bowel diseases, dementia, obesity.

Higher age predictions indicate a faster pace of aging in these conditions, which begs the question: is a higher aging rate a precondition to them or is it just an epigenetic footprint of the harm they cause? The authors plan to further investigate the links between epigenetics and longevity using DeepMAge.

According to an author of the published article, Fedor Galkin: " Aging clocks have come a long way since the first works by Horvath and Hannum in 2013. We are happy to contribute to this research field. Now, we are going to explore how epigenetic aging can be slowed down with the interventions available to consumers". Neural network architecture, which DeepMAge is based on, can be modified to digitally emulate the effects of fasting, taking longevity supplements, physical training, and other lifestyle changes.

Credit: 
Deep Longevity Ltd

Coronavirus pneumonia and pulmonary thromboembolism

Coronavirus Pneumonia and Pulmonary Thromboembolism
https://doi.org/10.15212/bioi-2020-0030

Announcing a new publication for BIO Integration journal. In this article the authors Mingkang Yao; Phei Er Saw and Shanping Jiang from Sun Yat-Sen University, Guangzhou, China review Coronavirus Pneumonia and Pulmonary Thromboembolism.

In this review, the authors summarize the harmful effects of that coronavirus pneumonia and highlight the clinical relationship between PTE and coronavirus infection. Potential mechanisms and prophylaxis and therapeutic measures are also discussed.

The COVID-19 global pandemic has severely threatened public respiratory health and medical services. Coagulation disorders, especially pulmonary thromboembolism (PTE), has proved to be a complication in severe COVID-19 patients, with the incidence of PTE causing poor clinical outcome and increased fatality.

It is important that healthcare providers recognize that patients with COVID-19 are at increased risk of PTE, and ensure that appropriate prophylaxis is administered to the appropriate patients, and that they effectively manage PTE when it does occur.

The mechanism of PTE in patients with coronavirus pneumonia consists of endothelial injury, activated platelet, cytokine storm, and a suppressed fibrinolytic system. Early prophylaxis, antiviral therapy, anticoagulation, and supportive treatment are beneficial to COVID-19 patients.

In this review, the authors summarize the harmful effects of that coronavirus pneumonia and highlight the clinical relationship between PTE and coronavirus infection. Potential mechanisms and prophylaxis and therapeutic measures are also discussed.

Credit: 
Compuscript Ltd

Better benzene sensing at laser point

video: KAUST researchers have developed a laser-based sensor that could improve monitoring of benzene emissions and limit exposure to this pollutant.

Image: 
© 2020 KAUST; Anastasia Serin

A laser-based sensor developed at KAUST could improve monitoring of benzene emissions and limit exposure to this pollutant. In collaboration with Saudi Aramco, KAUST researchers have developed a device that accurately senses extremely low concentrations of benzene in real time.

Benzene can cause serious health conditions, including cancer and the blood-related disease aplastic anemia. This harmful volatile compound, which originates from natural sources and human activities, mainly exists in industrial settings ranging from crude oil and petrochemical processing facilities to service stations, putting the health of workers at risk. It is also present in vehicle exhaust, biomass-based heating fuels and some consumer products, which can lead to dangerous exposure.

Typical approaches designed to control benzene emissions rely on gas chromatography and mass spectrometry but demand stringent maintenance schedules, complex sampling protocols and time-consuming measurements. Commercially available sensors present interference problems from other ambient air components and detection limits exceeding 100 parts per billion, failing to meet the recommended thresholds.

Now, a team led by Aamir Farooq--in a project funded by Saudi Aramco's Environmental Protection Department--has developed a compact laser-based sensor that exhibits high selectivity and sensitivity to benzene with a detection limit of 2 parts per billion, outperforming existing devices. Robust enough for field applications, the sensor performs measurements in seconds without preliminary calibration.

To achieve this unprecedented sensitivity, the researchers designed a sensor with walls that comprise two parallel concave mirrors that face each other to form a cavity around the sample. The cavity traps the laser beam, which keeps reflecting back and forth between the mirrors. "In this way, it travels a dramatically larger distance through the sample than the inter-mirror separation," explains Ph.D. student Mhanna Mhanna, who performed the experiments. "It enables us to detect concentrations that are three orders of magnitude lower than in a conventional sensor," he adds.

Farooq's team optimized the light absorption of benzene by selecting the laser wavelength and mathematically eliminating any interference from methane, ethylene and water vapor. This provided accurate benzene concentrations in the presence of interfering components.

The sensor detected trace benzene in real samples collected from various locations. For example, the sensor detected higher benzene concentrations in parking garage on weekdays than on weekends, consistent with traffic conditions. Service stations showed the highest levels, but these amounts were well below recommended thresholds.

"The sensor could be attached to a drone or carried by hand to scan target areas daily for benzene emissions," Mhanna says. The team is also looking into ways to make the sensor more portable.

Credit: 
King Abdullah University of Science & Technology (KAUST)

COVID-19: persistent symptoms in one third of cases

Since its appearance in early 2020, COVID-19 has been unpredictable for both physicians and affected individuals given the variety and duration of its symptoms. Notably, it appears to have the potential to cause an unusually long-lasting illness, and the term "long COVID" describes the disease in people who continue to report symptoms several weeks following the infection. To better understand this phenomenon, a team of physicians and epidemiologists from the University of Geneva (UNIGE) the University Hospitals of Geneva (HUG) and the General Health Directorate of the State of Geneva followed nearly 700 people who tested positive for SARS-COV2 but did not require hospitalisation. Six weeks after diagnosis, 33% of them still reported suffering from fatigue, loss of smell or taste, shortness of breath or cough. These results, which can be seen in the Annals of Internal Medicine, call for better communication, particularly with patients and with the physicians who follow them, and for ongoing messages to the general public, reminding them that SARS-CoV-2 infection is not trivial.

Even if in just a few months medical and scientific knowledge about SARS-COV2 has considerably improved, several aspects of this disease remain unknown. In particular, many people are wondering about the evolution and long-term consequences of this novel virus. "As soon as the pandemic arrived in our country, we were confronted with these questions," reports Professor Idris Guessous, physician epidemiologist at the Department of Community Health and Medicine of the UNIGE Faculty of Medicine and Chief Physician of the Division of Primary Care at HUG, who directed this work. "In March, the COVICARE program was set up to offer remote monitoring to patients who can be followed on an outpatient basis, when this follow-up could not be carried out by the primary care physician. This has enabled us to better understand the evolution of the disease in people who generally suffer neither from specific risk factors nor from a serious form of the disease."

Some Very Tired Patients

A total of 669 people were followed (mean age 43 years, 60% female, 25% of healthcare professionals and 69% without underlying risk factors that could be related to complications from COVID-19). At 6 weeks from diagnosis, nearly a third of participants still had one or more symptoms related to COVID-19, mainly fatigue (14%), shortness of breath (9%) and loss of taste or smell (12%). In addition, 6% reported a persistent cough and 3% reported headaches. Dr. Mayssam Nehme, Senior Resident in Professor Guessous's team and first author of this work, also explains how these patients felt: "In addition to the physical distress of their symptoms, many were very worried: how much longer would it last? Were some after-effects irrecoverable? Even without a clear medical answer, in the current state of knowledge, it is important to accompany concerned patients and to listen to them," she adds. With this in mind, the HUG has set up a specific consultation for long COVID patients in order to improve their care and guide them through the health system.

Better Understanding for Better Information

The persistence of symptoms must be recognised in order to legitimise the concerns of patients faced with a new and unknown disease, and to optimise their management. "This requires an information campaign towards the general public and healthcare workers, but also, more broadly, among employers, insurance companies and society in general. Everyone should realise that previously healthy people can also be affected by COVID-19, weeks or even months following the infection. Prevention is therefore of the utmost importance," add the authors, who are continuing their studies to understand the long-term evolution of these patients. Indeed, a follow-up of the same cohort 3 months, 7 months and 12 months following the infection is in progress.

Credit: 
Université de Genève

Research news tip sheet: story ideas from Johns Hopkins Medicine

image: Illustration for Research Story Tips from Johns Hopkins Medicine

Image: 
Johns Hopkins Medicine

UTERINE FIBROIDS CAN TAKE A HEAVY EMOTIONAL TOLL ON WOMEN, STUDY SHOWS

Media Contact: Marisol Martinez, mmart150@jhmi.edu

In a comprehensive review of 57 research studies looking at the quality of life of women with uterine fibroids compared with that of people with other chronic diseases, Johns Hopkins Medicine researchers found that the psychological and social burden of the condition is comparable with those for heart disease, diabetes or breast cancer.

The findings, published in the Nov. 1, 2020, issue of the American Journal of Obstetrics & Gynecology, suggest that fibroids affect a woman's quality of life both physically and emotionally. Furthermore, the condition may become a disability in terms of bodily pain, mental health, social functioning and satisfaction with sex life.

Uterine fibroids are the most prevalent benign gynecologic tumors, affecting up to 80% of women of reproductive age. They are made of smooth muscle cells and fibrous connective tissue, and their cause is unknown. One in four women with fibroids may experience heavy menstrual bleeding, anemia, abdominal pain or pressure, increased urinary frequency, and infertility or recurrent miscarriages.

"Over half of the women in the United States will have fibroids, so their overall impact is substantial and yet, this fact does not receive enough attention," says James Segars Jr., M.D., director of the Division of Reproductive Science and Women's Health Research, and professor of gynecology and obstetrics at the Johns Hopkins University School of Medicine.

Women with fibroids, the study states, may experience debilitating feelings of worry, fear, anxiety, insecurity and helplessness, as well as issues with self-image and depression. Moreover, the findings show that lack of control over the condition is a leading cause of distress.

"For some women, the unpredictability and intensity of the heavy bleeding and related symptoms associated with the condition go beyond an inconvenience," says Segars. "Many women suffer in silence, and feel they can't go out or be social because they may start bleeding at any time."

Treatment for uterine fibroids depends on the condition's severity. Medication may be used to help shrink the size of the fibroids or they may be surgically removed. With fibroids resulting in approximately 600,000 hysterectomies per year, the tumors are the second most common reason for surgery among pre-menopausal women.

Segars is available for interviews.

FOR BLACKS WITH RESPIRATORY ILLS, INDIVIDUAL AND NEIGHBORHOOD POVERTY YIELD WORSE OUTCOMES

Media Contact: Helen Jones, hjones49@jhmi.edu

Research has shown that African Americans have worse health outcomes than non-Hispanic whites regarding respiratory illnesses such as chronic obstructive pulmonary disease (COPD). Now, a new study by Johns Hopkins Medicine researchers reveals that much of this racial disparity can be explained by differences in the socioeconomic status of individuals and neighborhoods.

The findings were published Oct. 2, 2020, in the American Journal of Respiratory and Critical Care Medicine.

In their study, the researchers looked at 2,649 current and former smokers, with or without COPD. They assessed racial differences for different COPD characteristics, including symptoms; results of functional and imaging tests, including scores on a COPD Assessment Test (the questionnaire that measures COPD's impact on a person's life); the ability to perform a six-minute walk test; and the risk for severe worsening of symptoms.

Then, they compared the Black participants with the white participants regarding the socioeconomic status reported by each person and federal data on neighborhood poverty levels. The researchers adjusted for several known risk factors influencing respiratory health outcomes, including smoking status and pack-years (calculated by multiplying the number of packs of cigarettes smoked per day by the number of years a person has smoked).

"We found that Black study participants fared worse than their non-Hispanic white counterparts in a number of areas, including respiratory symptoms, quality of life measures, functional status and imaging findings, as well as having higher rates of severe exacerbations," says study lead author Chinedu Ejike, M.D., M.P.H., a postdoctoral research and clinical fellow at the Johns Hopkins University School of Medicine. "However, several but not all of these racial differences could be explained by lower socioeconomic status and living in poor neighborhoods."

The researchers say that low individual socioeconomic status has previously been associated with higher odds of having COPD, and according to their recent study's findings, residing in lower-income neighborhoods also has detrimental associations with respiratory morbidity. Several factors, they explain, associated with living in disadvantaged neighborhoods -- such as higher stress, poor access to health care, lower quality of care, lack of access to healthy food, exposure to environmental contamination, poor neighborhood walkability and diminished physical activity -- may affect COPD outcomes.

"Thus, to fully understand racial disparities with COPD, one must take into consideration where people live," says Ejike.

"Our work adds to the understanding of the complex relationship among race, socioeconomic status -- both at the individual and neighborhood levels -- and respiratory health outcomes," says study co-author Han Woo, Ph.D., a biostatistician at the Johns Hopkins University School of Medicine.

Ejike and Woo hope their study will encourage health care providers to develop strategies that can break the current link between socioeconomic disadvantage and poor health outcomes.

In further research, they plan to (1) identify more risk factors leading to increased respiratory morbidity among Blacks with COPD, (2) understand why neighborhood context plays a role in COPD health and (3) examine constructs of a neighborhood, such as residential segregation, that contribute to the racial gap in COPD health.

Ejike and Woo are available for interviews.

LYME DISEASE BACTERIA ALTER IMMUNE SYSTEM AND MAY CAUSE IT TO ATTACK HEALTHY CELLS

Media Contact: Waun'Shae Blount, wblount1@jhmi.edu

With the incidence of Lyme disease rising to over 300,000 new U.S. cases annually, more people are suffering with the debilitating and persistent symptoms associated with what clinicians call post-treatment Lyme disease syndrome. Now, researchers at the Johns Hopkins Lyme Disease Research Center have found that the bacterium behind the disease, Borrelia burgdorferi, causes significant changes in how the human body responds to its presence.

In a recent study, the researchers showed that Borrelia burgdorferi alters dendritic cells, which normally present antigens -- proteins from pathogens such as bacteria and viruses -- to immune system T-cells, signaling an immune response against the foreign invaders. However, Borrelia burgdorferi stops this communication, which may then lead to the immune system mistakenly attacking healthy cells.

A report on the findings were published in the September 2020 issue of Frontiers in Medicine.

"We believe these observations are relevant not only to how Borrelia burgdorferi disrupts the immune system but other infections as well," says senior author Mark Soloski, Ph.D., co-director for basic research at the Johns Hopkins Lyme Disease Clinical Research Center, and professor of medicine at the Johns Hopkins University School of Medicine. "Antibodies that react with a person's own tissues or organs have been reported in patients with infections, including COVID-19."

In an attempt to better understand how a Lyme disease infection contributes to weakening the immune system, the Johns Hopkins Medicine researchers isolated dendritic cells from healthy study participants and exposed them to Borrelia burgdorferi. They found that bacterial infection causes receptor sites on the surface of dendritic cells, known as HLA-DRs, to mature and become active. HLA-DRs normally present antigens to killer T-cells, the immune system agents that remove invaders from the body.

However, the researchers believe that when the HLA-DRs interact with Borrelia burgdorferi, they are structurally changed and keep the dendritic cells from "marking" the bacterial proteins as foreign. As a result, the dendritic cells attract T-cells but in response to healthy cells in the area rather than the Lyme disease microbes.

The researchers further surmise that if a person has a genetic predisposition to autoimmune diseases such as lupus or rheumatoid arthritis, infection by Borrelia burgdorferi may trigger their development.

Future research on HLA-DR and dendritic cell response to Borrelia burgdorferi, the researchers say, could contribute to new treatments for Lyme disease and a better understanding of how autoimmune diseases may arise.

Soloski is available for interviews.

BRAIN IMPLANTS ENABLE MAN TO SIMULTANEOUSLY CONTROL TWO PROSTHETIC LIMBS WITH 'THOUGHTS'

Media Contact: Brian Waters, bwaters3@jhmi.edu

In what is believed to be a medical first, researchers from Johns Hopkins Medicine (JHM) and the Johns Hopkins University Applied Physics Laboratory (APL) have enabled a quadriplegic man to control a pair of prosthetic arms with his mind.

In January 2019, surgeons implanted six electrodes into the brain of Robert "Buz" Chmielewski, during a 10-hour operation. The goal was to improve the sensation in his hands and enable him to mentally operate his prostheses. For more than three decades after a surfing accident while in his teens, Chmielewski has been paralyzed with only minimal movement in his arms and hands.

Now, almost two years into the joint JHM/APL research study following the surgery, Chmielewski has reached an important milestone -- he can now use both of his robotic appendages to perform simple tasks such as feeding himself.

"This type of research, known as brain-computer interface [BCI], has for the most part focused on only one arm, controlled from only one side of the brain," says Pablo Celnik, M.D., professor and director of physical medicine and rehabilitation at the Johns Hopkins University School of Medicine and a member of the research team. "Thus, being able to control two robotic arms performing a basic activity of daily living -- in this case, cutting a pastry and bringing it to the mouth using signals detected from both sides of the brain via implanted electrodes -- is a clear step forward to achieve more complex task control directly fed from the brain."

"Simultaneous brain-machine interface control of two limbs is a particular challenge because it's not a simple 1+1 summation of what the left arm is doing plus what the right arm is doing in the brain, but more like trying to calculate the sum of the two arms as 1 plus 1 equals 3.8," adds Gabriela Cantarero, Ph.D., assistant professor of physical medicine and rehabilitation at the Johns Hopkins University School of Medicine and a member of the research team.

The technology uses a system of devices that automates a portion of the robotic control with artificial intelligence.

"Our goal is to make activities, such as eating, easy to accomplish by having the robot do one part of the work and leaving the user in charge of the details: which food to eat, where to cut, how big the cut piece should be, and so on," says David Handelman, Ph.D., a senior roboticist at APL and a member of the research team. "By combining brain-computer interface signals with robotics and artificial intelligence, we allow the user to focus on the parts of the task that matter most."

"Our next steps for this work include expanding the number and types of activities of daily living that we can demonstrate with this form of human-machine teaming, as well as providing users with additional sensory feedback as tasks are conducted," says Francesco Tenore, Ph.D., an electrical engineer at APL and a member of the research team. "This means that the user won't have to rely entirely on vision to know if he's succeeding, in the same way that uninjured people can 'feel' how they're tying their shoelaces without having to look."

A recent video shows Chmielewski cutting food with his left hand and feeding himself with the right, at times simultaneously controlling both robot arms.

All of the researchers are available for interviews.

Credit: 
Johns Hopkins Medicine

Human systems management critical for businesses during COVID-19

image: This word cloud encapsulates the three key concepts underlying the articles included in this special thematic issue of Human Systems Management: The pandemic challenges (increased responsibility on health and safety problems, local vs. global, importance of micro-knowledge etc.); new organizational experiences related to learning, education, knowledge management; and exploration of the human side of the enterprise in the new conditions of work processes development. Word cloud created using Wordclouds.com software.

Image: 
Wordclouds.com software

Researchers share important information and solutions related to the challenges facing human resources and system managers in a special issue of Human Systems Management

Amsterdam, NL, December 8, 2020 - The COVID-19 pandemic has disrupted all types of organizations, leading human resources managers to reconsider their roles to support the implementation of social distancing practices, safety measures, and new ways of working. A special issue of Human Systems Management looks at the behavioral challenges posed by new ways of working and presents new models and tools to help organizations manage the transition.

"The most significant challenges organizations must overcome during the pandemic relate to human systems change management," explained Guest Editor Prof. Anca Draghici, PhD, Faculty of Management in Production and Transportation, Politehnica University of Timisoara, Romania; and President of the Ergonomics and Workplace Management Society in Romania. "Most organizations do not know how to manage the transition to a 'new normal,' or indeed may not even believe change is necessary."

The papers in this issue take a critical look at the challenges posed directly by the pandemic and explore new working models in new working environments, such as increased organizational responsibility and new paradigms for health and safety; new organizational experiences related to learning, education and knowledge management; and the human side of the enterprise under new conditions using new tools that require specific employees' skilling, re-skilling, and up-skilling.

Contributions explore:

Virtual working and teams dealing with crises and catastrophes. How to convert the COVID-19 and similar crises into opportunities for keeping businesses on track for growth.

A "learning by doing" framework for micro-knowledge management. This framework can ensure that knowledge learned by individuals working on projects is shared and integrated into project management tools and resources.

A digital service approach to foster team autonomy, distant collaboration, and knowledge sharing. A "self-service" kit for distance learning and team coaching.

The impact of employee engagement on organizational performance during COVID-19. Knowledge sharing has a mediating effect and human resource managers must think about how to direct this opportunity in the virtual setting.

How the National Human Capital Index influences productivity in research and development firms. It influences firm productivity in the long run, but larger and more financially stable firms record higher total factor productivity.

An easier and more comprehensive structural framework to identify risks in a 4.0 working environment. Companies that offshored their production and operate in the international business environment are studied to identify risk factors related to the work environment and human resources.

The challenges educators face during emergency remote learning. A comparison of education continuity measures concludes that a hybrid approach, combining face-to-face with online learning is the way forward in the "new normal."

The importance of learning organizations during times of risk and disruption. Cooperation and collaboration inside and outside of school boundaries and continuous learning opportunities for staff support the "school as learning organization" model.

A debate about implementing immersive technology for higher education. Participants in virtual reality training applications rate the experience much higher than common learning methods.

A global study of youth perception about their post-pandemic future. They see hope in the future and provide insights on areas of strength and weakness in programs, schemes, and curriculum in their communities.

A novel approach for improving stakeholders' commitment and responsibility for occupational health and safety (OHS) practices in an organization. An OHS Responsibility Multilevel Model for the implementation of the OHSAS 18001: 2007 standard.

Preventing and controlling back pain in computer workers. Treatment by an interdisciplinary team that includes an occupational physician, an ergonomist, and a physiotherapist can improve the health status of these workers.

"During the last eight months we have all recognized rapid progress in the implementation and use of technology, particularly web and cloud technologies, digitization, and also, intelligent automation. This change of culture makes human resources and work management key issues in this adaptation process," commented Prof. Draghici.

Credit: 
IOS Press

Scientists shed new light on how lung bacteria defend against pneumonia

image: Streptococcus pneumoniae, the bacteria responsible for pneumonia

Image: 
Janice Haney Carr, Centers for Disease Control and Prevention's Public Health Image Library (CC0 1.0)

New insight on how bacteria in the lungs protect against invading pathogens has been published today in the open-access eLife journal.

The study in mice shows that a strain of lung bacteria called Lactobacillus provides a barrier against Streptococcus pneumoniae (S. pneumoniae) colonisation in animals previously infected with influenza A virus when applied therapeutically following infection. S. pneumoniae can cause severe pneumonia especially in elderly patients. In light of increasing antibiotic resistance, these findings suggest that probiotics may offer an alternative treatment approach for bacterial lung infections.

In healthy organisms, 'commensal' bacteria, which live inside the host without harming it, provide a competitive barrier against invading bacterial pathogens. "It is already well known how commensal bacteria in the gut fight off pathogens," explains co-first author Soner Yildiz, Postdoctoral Research Fellow at the University of Geneva, Switzerland. "But how lung bacteria such as Lactobacillus carry out this role is less clear."

To address this gap, Yildiz and colleagues studied the role of lung microbiota against Pneumococcus colonisation in mice. The team had previously reported that a significant amount of Lactobacillus bacteria, which are known to act as antimicrobials and immune system modulators, exist in the lung microbiota of healthy mice. In the current study, they identified these commensal bacteria as Lactobacillus murinus (L. murinus), with further gene sequencing and microscopy showing that the bacteria are tightly associated with mouse lung tissue.

The team next exposed cultures of L. murinus to S. pneumoniae. They found that L. murinus inhibited the growth of the pathogen through the release of lactic acid. "This antibacterial activity was not limited to S. pneumoniae," says co-first author João Pereira Bonifacio Lopes, PhD student at the University of Geneva. "It also affected S. aureaus, the pathogen that can cause bloodstream, bone and joint infections, as well as pneumonia."

Finally, they treated mice with L. murinus following influenza A infection and found that the bacteria provided a barrier against pneumococcal colonisation in the animals.

"This suggests that resident commensals in the lung could be applied as probiotics to counteract lung colonisation by pathogenic bacteria," concludes senior author Mirco Schmolke, Group Leader at the University of Geneva. "However, further studies are needed before this can be explored as a potential treatment in humans. If it one day proves to be effective, the approach could improve the clinical outcomes for patients who are susceptible to respiratory tract infections."

Credit: 
eLife

The Lancet: Oxford COVID-19 vaccine is safe and protects against disease, first published results from phase 3 trials

First full results from interim analysis confirm that the Oxford COVID-19 vaccine (AZD1222) has an acceptable safety profile and is efficacious against symptomatic COVID-19 disease, with no hospitalisations or severe disease reported in the COVID-19 vaccine group so far

First clinical efficacy results of the vaccine are based on a pre-specified pooled analysis of phase 3 trials in UK and Brazil (11,636 people), alongside safety data from a total of 23,745 participants in 4 trials in the UK, Brazil and South Africa

Interim results of the Oxford COVID-19 vaccine trials find that the vaccine protects against symptomatic disease in 70% of cases - with vaccine efficacy of 62% for those given two full doses, and of 90% in those given a half then a full dose (both trial arms pre-specified in the pooled analysis). The results are the first full peer-reviewed efficacy results to be published for a COVID-19 vaccine, and are published in The Lancet.

The vaccine was found to be safe, with only three out of 23,745 participants over a median of 3.4 months experiencing serious adverse events that were possibly related to a vaccine; one in the vaccine arm, one in the control arm, and one in a participant who remains masked to group allocation. All participants have recovered or are recovering, and remain in the trial.

Study author, Dr Merryn Voysey, University of Oxford, UK, says: "The results presented in this report provide the key findings from our first interim analysis. In future analyses, with more data included as it becomes available, we will investigate differences in key subgroups such as older adults, various ethnicities, doses, timing of booster vaccines, and we will determine which immune responses equate to protection from infection or disease." [1]

Study lead author Professor Andrew Pollard, University of Oxford, UK, says: "Control of the pandemic will only be achieved if the licensing, manufacturing and distribution of these vaccines can be achieved at an unprecedented scale and vaccination is rolled out to those who are vulnerable. Our findings indicate that our vaccine's efficacy exceeds the thresholds set by health authorities and may have a potential public health impact." [1]

The Oxford COVID-19 vaccine uses a chimpanzee adenovirus viral vector that cannot cause disease in humans and expresses the SARS-CoV-2 spike protein. This means the vaccine delivers the spike protein genetic code into vaccinated people's cells, which then produce the protein, and teaching the immune system to recognise and attack the virus. Past trial results have found that the vaccine induces antibody and T cell immune responses, and is safe in adults aged 18 years and over, including older adults [2].

For the new study, the authors analysed data from 23,745 adults in the UK, Brazil and South Africa (11,730, 10,002, and 2,013 in each country, respectively). The interim analysis published today pools the data from these for analysis, providing greater precision for efficacy and safety outcomes than possible in individual trials and giving a broader understanding of the use of the vaccine in different populations [3].

In the trial, half of the participants were given the COVID-19 vaccine and the other half given a control (either a meningococcal conjugate vaccine or saline [4]). The trial was originally designed to assess a single dose of the vaccine, but following review of the immune response data in the UK phase 1/2 study (which found a second dose boosted immune responses) another dose was added to the trial protocol, then, once approved, second doses were given to participants.

Participants in the COVID-19 vaccine group received two doses each containing 5x1010 viral particles (a standard dose). However, a subset (1,367 people) in the UK received a half dose as their first dose, followed by a full second dose. This was because of differences in the results of quantification methods between batches of the vaccine. The low-dose/standard-dose group did not include adults over the age of 55 years as the low-dose was given in an early stage of the trial before recruitment of older adults had commenced.

The authors used the numbers of cases of symptomatic and asymptomatic infection to determine vaccine efficacy.

Overall, most participants were aged 18-55 years (82%,19,588/23,745) as people aged 56 years and older were recruited later and will be studied in future analyses of the trial. In the 11,636 people included in the vaccine efficacy against symptomatic disease analysis, 12% (1,418/11,636 people) were older adults and most were white (83%, 9,625/11,636 people).

Findings from the trial safety data

Safety was monitored for a median of 3.4 months in all 23,745 participants from the UK, Brazil and South Africa. Out of 23,745 participants, 168 experienced a total of 175 severe adverse events over the period, but 172 events were unrelated to the COVID-19 or control vaccines. One event was in the control group (a case of haemolytic anaemia), one event was in the COVID-19 vaccine group (a case of transverse myelitis considered possibly related to the vaccine), and a case of severe fever (> 40oC) was reported in South Africa in a participant who remains masked to group allocation and recovered rapidly without an alternative diagnosis and was not hospitalised. All three participants have recovered or are recovering, and continue to be part of the trial.

Safety monitoring of all participants in the trial continues.

Vaccine efficacy against symptomatic COVID-19 disease

The primary outcome of the study was to determine how many cases of symptomatic COVID-19 disease (confirmed by positive test, and the participant having a fever, cough, shortness of breath, or loss of smell or taste) there were in participants who had received two doses of the vaccine (with the first dose being either low or standard dose, and the second dose being standard dose), compared with controls. Only cases that occurred 14 days after the second vaccination had been given were included (11,636 participants in the UK and Brazil trials).

There were 131 cases of symptomatic COVID-19 disease more than 14 days after the second vaccine dose in these 11,636 people. This included 30/5,807 (0.5%) cases in the vaccine group and 101/5,829 (1.7%) cases in the control group, which equates to a vaccine efficacy of 70%.

When breaking this down based on vaccine dose, those who received two standard doses of the vaccine saw a vaccine efficacy of 62% (based on 27/4,440 (0.6%) cases in the vaccine group, and 71/4,455 (1.6%) cases in the control group), and the low-dose/standard-dose group vaccine efficacy was 90% (based on 3/1,367 (0.2%) cases in the vaccine group, and 30/1,374 (2.2%) cases in the control group).

The authors completed exploratory subgroup analyses at the request of peer-reviewers to study the difference in efficacy against symptomatic disease in the low-dose/standard-dose group and two standard doses group. These were to help understand whether the difference was related to the dose or other factors (participant age and time between vaccine doses [5]). They found that, irrespective of age or time between doses, their analyses suggested higher efficacy in the low-dose/standard-dose group. However, these exploratory analyses provide a suggestion, and will require further research as more data becomes available from the trial.

Five cases of symptomatic COVID-19 disease occurred in people aged over 55 years old, but vaccine efficacy in older age groups could not be assessed as there were too few cases. The authors say that this analysis will be completed in future.

"In order to assess vaccine efficacy, we need to have a sufficient number of COVID-19 cases among participants to indicate that the vaccine is protecting them from disease. Since recruitment of older adults started later than in younger adults there has been less follow up time for these cohorts and less time to accrue COVID-19 cases. This means we have to wait longer to have sufficient data to provide good vaccine efficacy estimates in smaller subgroups." says Dr Voysey. [1]

Asymptomatic transmission

The trial also measured protection against asymptomatic infection by asking 6,638 UK participants to complete weekly COVID tests. However, it is important to note these data are secondary outcomes [6] and findings need to be confirmed when there is more data available from the trial.

There were 69 cases of asymptomatic COVID-19 disease identified in the UK study's weekly COVID-19 testing of 6,638 people. This included 29/3,288 (0.9%) cases in the vaccine group, and 40/3,350 (1.2%) cases in the control group, leading to a vaccine efficacy against asymptomatic transmission of 27%.

In the low-dose/standard-dose group, there were 7/1,120 (0.6%) cases in the vaccine group and 17/1,127 (1.5%) cases in the control group, resulting in a vaccine efficacy against asymptomatic transmission of 59%. In people given two standard doses, there were 22/2,168 (1%) cases in the vaccine group and 23/2,223 (1%) in the control group, which equates to a vaccine efficacy against asymptomatic transmission of 4%.

Protection against severe disease

Cases of severe disease and hospitalisation were monitored for in all 23,745 participants. From 21 days after the first dose there were 10 cases hospitalised for COVID-19, all in the control arm, and two were classified as severe, including one death. These are also secondary outcomes and will require additional confirmation.

Co-author, Professor Sarah Gilbert, University of Oxford, UK, says: "Despite global spread of COVID-19, a large proportion of the population in many countries have not been infected and are not immune. Vaccines may play an important role in increasing immunity, preventing severe disease, and reducing the health crisis, so the possibility that more than one efficacious vaccine may be approved for use in the near future is encouraging. Here we have shown for the first time that an adenoviral vectored vaccine - a type of vaccine technology which has been in use since 2009 - is efficacious and could contribute to disease control in the COVID-19 pandemic." [1]

The authors note that they are not yet able to assess duration of protection, as the first trials were initiated in April 2020 and all disease episodes have accrued within six months of the first dose being administered. Further evidence will be required to determine duration of protection and the need for additional booster doses of vaccine.

Writing in a linked Comment, Dr Maria Deloria Knoll and Dr Chizoba Wonodi, Johns Hopkins Bloomberg School of Public Health, USA (who were not involved in the study), say: "Oxford-AstraZeneca's US$2-3 per dose agreement with the COVAX facility holds good promise for equitable access for LMICs, compared with the high cost of the two mRNA vaccines that have also reported more than 90% efficacy. The ChAdOx1 nCoV-19 vaccine can also use routine refrigerated cold chain, which is important since the ultra-low temperature freezers required to store mRNA vaccines could be unaffordable and impractical in many countries and in settings such as nursing homes. However, other challenges with any two-dose regimen will exist in many LMICs where platforms to easily identify, locate, and reach--twice-- adults targeted for vaccination are lacking. If the two vaccine injections require different doses, this will add complexity for health workers with little formal training, but can be managed with innovative packaging and proper change management to reduce errors... When faced with vaccine choices, National Immunization Technical Advisory Groups will have to consider all factors and decide which vaccine is right for their setting. Efficacy is an important consideration, but so are pragmatics of delivery, community acceptance, longevity of effect, whether a vaccine reduces infection and transmission as well as disease, efficacy in high-risk groups, and, of course, safety. Despite the outstanding questions and challenges in delivering these vaccines, it is hard not to be excited about these findings and now the existence of three safe and efficacious COVID-19 vaccines, with 57 more in clinical trials. With a range of manufacturers, a very large global investment in production and cooperation in procurement and distribution, it seems likely that 2021 will see COVID-19 vaccines made available to all countries in the world. Perhaps by this time next year, we can celebrate the global control of SARS-CoV-2, in person."

Credit: 
The Lancet